Evolutionary Genomics, Inc.: 10-Q filed 2012-08-14

Name: Evolutionary Genomics, Inc.: 10-Q filed 2012-08-14
Creator: Evolutionary Genomics, Inc.

What Evolutionary Genomics, Inc. reported in its quarterly report filed 2012-08-14 (fiscal Q2 2012): 17 published measures, 49 facts as tagged in accession 0000943440-12-000887.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-08-14
Fiscal period: fiscal Q2 2012
Accession: 0000943440-12-000887 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Evolutionary Genomics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	189	USD
At 2011-12-31	364	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-06-30	57,882	USD
At 2011-12-31	48,862	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	-57,693	USD
At 2011-12-31	-48,498	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	14	USD
At 2011-12-31	14	USD
At 2011-06-30	26	USD
At 2010-12-31	15	USD
At 2008-07-31	11	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-2,665	USD	91
2012-01-01 to 2012-06-30	-10,083	USD	182
2008-08-01 to 2012-06-30	-79,601	USD	1430
2011-04-01 to 2011-06-30	-1,919	USD	91
2011-01-01 to 2011-06-30	-9,163	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-8,170	USD	182
2008-08-01 to 2012-06-30	-76,579	USD	1430
2011-01-01 to 2011-06-30	-17,396	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	8,170	USD	182
2008-08-01 to 2012-06-30	76,582	USD	1430
2011-01-01 to 2011-06-30	17,407	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-06-30	-1,200,940	USD
At 2011-12-31	-1,200,940	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-1,776	USD	91
2012-01-01 to 2012-06-30	-9,196	USD	182
2008-08-01 to 2012-06-30	-78,712	USD	1430
2011-04-01 to 2011-06-30	-1,919	USD	91
2011-01-01 to 2011-06-30	-9,163	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	189	USD
At 2011-12-31	364	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	888	USD	91
2012-01-01 to 2012-06-30	888	USD	182
2008-08-01 to 2012-06-30	888	USD	1430

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	57,882	USD
At 2011-12-31	48,862	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-06-30	1,300	USD
At 2011-12-31	450	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	1,776	USD	91
2012-01-01 to 2012-06-30	9,196	USD	182
2008-08-01 to 2012-06-30	78,712	USD	1430
2011-04-01 to 2011-06-30	1,919	USD	91
2011-01-01 to 2011-06-30	9,163	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-06-30	7,894,111	shares
At 2011-12-31	7,894,111	shares

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-888	USD	91
2012-01-01 to 2012-06-30	-888	USD	182
2008-08-01 to 2012-06-30	-888	USD	1430

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2008-08-01 to 2012-06-30	20,000	USD	1430

Inspect the source

Entity: Evolutionary Genomics, Inc. / CIK 0000884363
Captured: 2026-09-22 19:32 UTC
SEC response SHA-256: a2b66772c1d0ab2271c82d2191d0de1fc92fc9df77b277aa7e747ea7abf31177

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000884363.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))